Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease

Published:2016-04-07 Issue:11 Volume:27 Page:3405-3412
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Kröpelin Tobias F.,de Zeeuw Dick,Remuzzi Giuseppe,Bilous Rudy,Parving Hans-Henrik,Heerspink Hiddo J.L.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference16 articles.

1. Microalbuminuria: target for renoprotective therapy PRO

2. Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View

3. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

4. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics

5. The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence;Cardiovascular Diabetology;2023-05-27

2. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58;Diabetes Care;2021-07-07

3. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease;Nature Communications;2019-04-23

4. Microvascular endothelial function is an independent predictor for albuminuria progression among Asians with type 2 diabetes-A prospective cohort study;Microcirculation;2018-04-27

5. Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease;Kidney International Supplements;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3